Sai-Lan Liu

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

Lin-Quan Tang, Dong-Ping Chen, Ling Guo et al. · The Lancet Oncology · 2018 · 150 citations

Medicine, Oncology, Radiation Oncology +14

TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition

Sai-Lan Liu, Huan-Xin Lin, Chuyong Lin et al. · Cancer Letters · 2017 · 60 citations

Medicine, Cancer Biology, Oncology +17

Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial

Sai-Lan Liu, Xiao-Yun Li, Jin-Hao Yang et al. · The Lancet Oncology · 2024 · 54 citations · Full text

Medicine, Oncology, Oncologic Surgery +11

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Xue-Song Sun, Li-Ting Liu, Sai-Lan Liu et al. · BMC Cancer · 2019 · 44 citations · Full text

Medicine, Oncology, Chemotherapy +16

Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients

Sai-Lan Liu, Huan-Xin Lin, Fang Qiu et al. · PLoS ONE · 2017 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +15